Table 1.
Genotype | Phenotype | Process | Activities | References |
---|---|---|---|---|
SIRT4 OE cells | Inhibition of insulin secretion in pancreas β cells | ADP-ribosylation and inhibition of GDH | ADP-ribosylation | (6–8) |
SIRT4 KO cells | Activation of GDH and stimulation of insulin secretion in insulinoma cells | Activation of GDH | ADP-ribosylation | |
SIRT4 KO mice | Increased insulin secretion, | Activation of GDH | ADP-ribosylation | |
SIRT4 KO mice | Deregulated lecuine metabolism and aging induced IR | Dysregulated leucine oxidation | deacylation | (9–11) |
SIRT4 OE cells | Increased lipogenesis and decreased FAO in adipocyte and myocyte cell | Deacetylation of MCD | deacetylation | (12–15) |
SIRT4 KO cells | Increased FAO in muscle and WAT cells | Activation of MCD and decreased malony-CoA | Deacetylation | |
SIRT4 KO mice | Elevated FAO and resistance to obesity and exercise | Activation of GDH | Deacetylation | |
SIRT4 OE cells | Depressed FAO in liver cells | Repression of PPARα transcriptional activation by SIRT1 | – | (12, 16–18) |
SIRT4 KO cells | Increased FAO rate | Activation of PPARα | – | |
SIRT4 KO mice | Increased FAO rate and PPARα pathway | Activation of FAO by PPARα and SIRT1 | – |
OE, over expression; KO, knock out.